This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Inserm (Institut National De La Santé Et De La Recherche Médicale), Université De Paris, Universite Paris Xiii Paris-Nord. Active years: 2026.
Company Filing History:
1 out of 21 
1 out of 68 
1 out of 8 
Years Active: 2026
Title: The Innovations of Peter Lenting
Introduction
Peter Lenting is a notable inventor based in Le Kremlin-Bicêtre, France. He has made significant contributions to the field of biomedical research, particularly in the development of innovative solutions to control bleeding.
Latest Patents
Lenting holds a patent for "Anti-protease Nexin-1 Conformational Single Domain Antibodies and Uses Thereof to Control Bleeding." This invention showcases his expertise in creating targeted therapies that can potentially improve patient outcomes in critical situations.
Career Highlights
Throughout his career, Peter Lenting has worked with prestigious institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. His work in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
One of his notable collaborators is Cécile Denis, with whom he has worked on various projects aimed at advancing medical research and innovation.
Conclusion
Peter Lenting's contributions to the field of biomedical research and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire future advancements in medical technology.